MedTrace Logo

Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.

NCT01729221 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2012-11-20

No results posted yet for this study

Summary

Prospective study to calculated the incidence of hepatocellular carcinoma in hepatitis C virus infected patients after stem cell therapy.

Conditions

  • Hepatocellular Carcinoma in Hepatitis C Virus Infected Patients

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Zekri Abdelrahman, M.SC, Ph,D · National Cancer Institute , Cairo University

  • Hosny Salama, M.D. · Cairo University

  • Zekri Abdelrahman, M.SC, Ph,D · National Cancer Institute, Cairo University

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-02-28
Completion
2013-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01729221 on ClinicalTrials.gov